This podcast episode explores the discovery and development of GLP-1-based drugs, with a focus on the work of Novo Nordisk. Lotte Bjerre Knudsen, Chief Scientific Advisor of Novo Nordisk, shares her insights on the scientific journey behind the development of these drugs for the treatment of diabetes and obesity. The episode highlights the challenges and strategies involved in the research and development process, the importance of collaboration and perseverance, and the impact of innovative thinking and the unique work culture at Novo Nordisk.
